PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: b.fisher@bham.ac.uk.\', \'Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.\', \'Kadoorie Centre for Critical Care Research, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.\', \'Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK; Department of Infectious Diseases, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Department of Critical Care Medicine, Royal Bolton Hospital, Bolton, UK.\', \'Department of Infectious Disease, Imperial College London, London, UK.\', \'Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.\', \'Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.\', \'Department of Critical Care Medicine, University Hospital of Wales, Cardiff, UK.\', \'Department of Respiratory Medicine, University College Hospital, London, UK.\', \'Jenner Institute, University of Oxford, Oxford, UK.\', \'Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.\', \'Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, Oxford, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(21)00460-410.1016/S2213-2600(21)00460-4
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 34922649
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all